Need professional-grade analysis? Visit stockanalysis.com
$50.60B
N/A
N/A
N/A
Pell Bio-Med Technology Co., Ltd. (6949) trades on TW in TWD. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at TWD770.00, down 1.28% from the previous close.
Over the past year, 6949 has traded between a low of TWD121.00 and a high of TWD782.00. The stock has gained 531.1% over this period. It is currently 536.4% above its 52-week low.
Pell Bio-Med Technology Co., Ltd. has a market capitalization of $50.60B.
Pell Bio-Med Technology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of chimeric antigen receptor T cell (CAR-T), and other related services and products. It offers autologous adipose-derived stem cell (ADSC) products to treat osteoarthritis and cartilage defects in the knee; cytokine-induced Killer cells to treat various tumors; and dendritic cell-activated cytokine-induced killer to treat solid tumors. The company is also involved in the phase 1/2 multicenter study to evaluate the safety and efficacy of CD19-targeted chimeric antigen receptor T-cell therapy in patients with relapsed or refractory B-cell lymphoma; a follow-up study of lentiviral-based gene-edited immune cell therapy. The company was founded in 2017 and is based in Taipei, Taiwan.
Side-by-side comparison against top Healthcare peers.